[Form 4] Transcat Inc Insider Trading Activity

Rhea-AI Filing Summary

Transcat, Inc. (TRNS) reporting person Cynthia Langston, a director, recorded equity award activity on Form 4. On 09/11/2025 Ms. Langston was reported to have acquired 704 shares through vesting or conversion of restricted stock units at $0 per share and continues to beneficially own 1,837 shares of common stock directly after the reported transactions. A prior grant of 1,587 RSUs (granted 09/10/2025) was noted as exempt under Rule 16b-3 and generally vests on 09/10/2026, while 1,587 RSUs vested on 09/10/2025 and converted one-for-one into common shares. Additionally, a stock option covering 10,000 shares with an exercise price of $73.80 and a five-year pro rata vesting schedule was reported.

Positive

• Director equity alignment: Vesting of RSUs converted to 704 shares on 09/11/2025, increasing direct ownership to 1,837 shares
• Clear disclosure: Grants and vesting schedules provided, including a 10,000-share option at $73.80 with pro rata five-year vesting

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received vested RSUs and an option grant; these are routine compensation events with limited immediate market impact.

The Form 4 discloses an insider compensation-related increase in direct holdings via RSU vesting and a standard time-vested stock option covering 10,000 shares at $73.80. The 704-share acquisition on 09/11/2025 was through RSU conversion at no cash price, increasing direct beneficial ownership to 1,837 shares. The separate 1,587-RSU grant is subject to a one-year vesting cliff to 09/10/2026. From a capital-markets perspective, these are governance/compensation items rather than transactional signals about company operations; absent material size context versus outstanding shares, market impact is likely neutral.

Corporate Governance Expert

TL;DR: Report shows standard director compensation through RSUs and an option with staged vesting; disclosure aligns with Rule 16 reporting expectations.

The filing clearly indicates awards granted under an exempt Rule 16b-3 transaction and subsequent vesting events. The separate RSU grants and the 10,000-share option with five-year pro rata vesting reflect common long-term alignment practices for directors. The Form 4 is complete regarding transaction dates, amounts, and exercise price, and was signed by an attorney-in-fact, which is typical for officer/director filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Langston Cynthia

(Last) (First) (Middle)

C/O TRANSCAT, INC.

35 VANTAGE POINT DRIVE

(Street)

ROCHESTER NY 14624

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSCAT INC [ TRNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.50 par value	09/11/2025		M		704	A	$0(1)	1,837	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
These restricted stock units (	$0(1)	09/10/2025		A		1,587		(2)	(2)	Common Stock, $.50 par value	1,587	$0	1,587	D
Restricted Stock Units	$0(1)	09/11/2025		M			704	(3)	(3)	Common Stock, $.50 par value	704	$0	0	D
Stock Option (Right to Buy)	$73.8							(4)	09/07/2032	Common Stock, $.50 par value	10,000		10,000	D

Explanation of Responses:

1. These restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

2. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 10, 2026.

3. These RSUs vested on September 11, 2025.

4. This option vests and becomes exercisable pro rata with respect to one-fifth of the shares subject to the option on the first, second, third, fourth and fifth anniversaries of the date of grant, except as otherwise provided in the award agreement.

	/s/ Kristina L. Johnston, Attorney-in-Fact for Cynthia Langston	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cynthia Langston report on Form 4 for TRNS?

The Form 4 shows conversion/vesting of RSUs resulting in 704 shares acquired on 09/11/2025 and reports beneficial ownership of 1,837 shares following the transactions; it also discloses a 10,000-share option at $73.80.

Did any restricted stock units (RSUs) vest for Cynthia Langston?

Yes. The filing states 1,587 RSUs vested/converted one-for-one into common stock (noting a grant of 1,587 RSUs that vest on 09/10/2026 and a separate 1,587 that vested on 09/10/2025).

What are the terms of the reported stock option?

The reported option covers 10,000 shares with an exercise price of $73.80 and vests pro rata over five anniversaries beginning from the grant date, with an expiration on 09/07/2032.

Was the Form 4 filing signed and who filed it?

The filing was signed by Kristina L. Johnston, Attorney-in-Fact for Cynthia Langston on 09/11/2025 per the signature block.